Capricor Therapeutics Inc
(FRA:4LN2)
€
3.7
+0.37 (+10.98%)
Market Cap: 206.04 Mil
Enterprise Value: -22.90 Mil
PE Ratio: 0
PB Ratio: 0.95
GF Score: 54/100 Capricor Therapeutics Inc (FRA:4LN2) Transcripts
- 1